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ABSTRACT 
The recently described ‘gasomediator’ hydrogen sulfide (H2S) has been involved in pain 
mechanisms, but its effect on pruritus, a sensory modality that similarly to pain acts as a 
protective mechanism, is poorly known and controversial. The effects of the slow-
releasing (GYY4137) and spontaneous H2S donors (Na2S and Lawesson’s reagent, LR) 
were evaluated in histamine and compound 48/80 (C48/80)-dependent dorsal skin 
pruritus and inflammation in male BALB/c mice. Animals were intradermally (i.d.) 
injected with C48/80 (3 µg/site) or histamine (1 µmol/site) alone or co-injected with 
Na2S, LR or GYY4137 (within the 0.3 - 100 nmol range). The involvement of endogenous 
H2S and KATP channel-dependent mechanism were also evaluated. Pruritus was assessed 
by the number of scratching bouts, whilst skin inflammation was evaluated by the 
extravascular accumulation of intravenously injected 125I-albumin (plasma extravasation) 
and myeloperoxidase (MPO) activity (neutrophil recruitment). Histamine or C48/80 
significantly evoked itching behavior paralleled by plasma extravasation and increased 
MPO activity. Na2S and LR significantly ameliorated histamine or C48/80-induced 
pruritus and inflammation, although these effects were less pronounced or absent with 
GYY4137. Inhibition of endogenous H2S synthesis exacerbated C48/80-induced 
responses, whereas the blockade of KATP channels by glibenclamide did not. High-
performance liquid chromatography coupled to tandem mass spectrometry (HPLC-
MS/MS) revealed that Na2S and LR, but not GYY4137, significantly attenuated C48/80-
induced histamine release from rat peritoneal mast cell in vitro. We provide first 
evidences that H2S exerted protective effect against acute pruritus mediated via 
histaminergic pathways in murine skin, thus making of H2S donors a potential 
alternative/complementary therapy for treatment of acute pruritus. 
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1. Introduction 
 
Pruritus (itch) is an autonomous pain-independent sensation that, similarly to pain, acts 
as a distressing physiological self-protective mechanism in both humans and animals. 
This response greatly affects life quality and can be triggered by inflammatory skin 
diseases, systemic diseases, neuropathic conditions and psychogenic disorders. 
According to the etiology, it may be acute or chronic (duration longer than 6 weeks), 
localized or generalized  [1], [2]. A range of mediators, such as histamine [3], 
prostaglandins  [4], serotonin [5], bradykinin [6], cytokines [7],  endothelin-1 [8], 
leukotrienes [9], proteases [10,11], neuropeptides [12] and opioids [13] orchestrate this 
response by acting on their receptors located on the nerve terminals. Pruritus (scratching 
behavior) is also a common symptom that results from insect bites, and can be 
experimentally induced in animals by the intradermal (i.d.) injection of insect saliva or 
venom toxins [12,14,15]. 
The management of pruritus, either dependent or independent of histaminergic pathways, 
is always recommended when removal of the trigger factors does not control the itch or 
perhaps unknown. Topical (e.g. anaesthetics, antihistamines, steroids, calcineurin 
inhibitors and capsaicin cream) or systemic approach (e.g. antihistamines, antidepressants 
and immunossupressors) are normally prescribed according to the etiology  [2].  
Interestingly, over the last ten years, hydrogen sulfide (H2S) a new mediator that belongs 
to the class of endogenous gases such as nitric oxide (NO) and carbon monoxide (CO), 
has emerged and brought about divergent findings regarding its role in acute / chronic 
inflammatory responses and nociception  [16–19]. However, the use of slow-releasing 
H2S donors (such as SG-1002, diallyl trisulfide and GYY4137) and hybrid H2S-releasing 
non steroidal anti-inflammatory compounds (such as the naproxen derivative ATB-346) 
strengthens the beneficial therapeutical effects of H2S in articular inflammation [20], 
colorectal cancer [21], periodontitis [22] and pain [23] with additional gastrointestinal 
safety [24]. More recently, low serum levels of H2S has been associated with psoriasis 
[25], a disease often associated with pruritus [26]. In contrast, Wang and co-workers [27] 
showed that the i.d. injection of high doses of NaHS or Na2S, but not GYY4137, evoked 
a dose-dependent scratching behavior in mice, which is possibly related to the H2S 
releasing rate. Considering that the results on the effects of H2S on itch behavior are rather 
limited and controversial, this study was carried out to evaluate whether slow and 
spontaneous-H2S releasing donors, used at low doses, are able to reduce acute pruritus 
and the related cutaneous inflammation mediated by histamine. 
 
2. Material and methods 
 
2.1. Animals 
Male BALB/c mice (20 - 30 g) and Wistar rats (180 - 200 g) were obtained from 
the local animal care facilities and housed in groups (up to five animals per cage) under 
standard controlled conditions (22°C; 12/12 h light/dark cycle) with free access to 
commercial rodent chow and water. All the experimental protocols were approved by the 
local ethics committee (CEUA–ICB; protocol n. 33, pgs. 85, book no. 02/2010), in 
accordance with the guidelines from the Brazilian Council for Control of Animal 
Experimentation (CONCEA) and the Directive 2010/63/EU, comprising with the Animal 
Welfare Act.  
 
2.2. Induction of pruritus (itching) in the mouse dorsal skin 
Mice were transitorily anaesthetized with inhaled isoflurane (3% v/v in O2) and 
the rostral part of the back ( 2 cm) near to the neck was shaved. Histamine (1 µmol/site), 
C48/80 (3 µg/site) or its corresponding vehicle Tyrode were i.d. injected, in a volume of 
50 μl, alone or in combination with 0.3-10 nmol/site of Na2S, Lawesson’s reagent (LR; 
both, spontaneous H2S donors) or the slow-release H2S donor GYY4137. Mice were 
individually placed into a perspex transparent box (12x20x17 cm; Insight, Brazil) in a 
quiet room adapted with video camera (Sony HDR-PJ230), where the mice were daily 
acclimatized for 40 min during the two days previous to the experiments. A maximum of 
four mice were simultaneously recorded during the same period and the number of 
scratching bouts were counted as detailed in  [12]. The number of scratching bouts was 
expressed either as absolute countings or as percentage values determined in 40 min. In 
all the experiments, the investigator who quantified the scratching behavior was unaware 
of the experimental group identities.  
 
2.3. Assessment of dorsal cutaneous plasma extravasation 
Mice were anesthetized with urethane (2.5 g/kg; i.p.), the rostral back shaved, and 
100 µl of 125I–bovine serum albumin (125I–BSA, 0.037 MBq) was intravenously (i.v.) 
injected via the tail vein. Histamine (30 nmol/site), C48/80 (3 μg/site) or Tyrode were i.d. 
injected alone or co-injected with Na2S, LR or GYY4137 (1–100 nmol/site) throughout 
six randomized skin sites as previously described [28]. The result were expressed as μl of 
plasma per g of tissue or percentage based on the control values (obtained with either 
histamine or C48/80 alone). 
 
 
2.4. Pharmacological treatments 
To investigate the involvement of KATP channel in H2S donors-mediated 
protective effects, a set of mice was pretreated (- 30 min), via intraperitoneal (i.p.), with 
the KATP channel blocker, glibenclamide (10 or 30 mg/kg, i.p.  [29]) or its corresponding 
vehicle carboxymethylcellulose (CMC; 0.1 ml, i.p.). In order to establish the effective 
dose of glibenclamide, another group of mice was pretreated (- 30 min) with 
glibenclamide 10 or 30 mg/kg and then i.d. injected with the KATP channel opener, 
pinacidil (10 - 30 nmol/site; i.d.). In order to assess the role of endogenous H2S in 
histamine-induced skin pruritus and skin inflammation, two independent groups of mice 
were pretreated (- 60 min; i.p.) with the CSE and CBS inhibitors β-cyanoalanine (BCA, 
50 mg/kg) and aminooxyacetic acid (AOAA, 20 mg/kg), a CSE and CBS inhibitors, 
respectively. 
 
2.5. Biochemical analysis 
 
2.5.1. Measurement of myeloperoxidase (MPO) activity 
Mice were anaesthetized with isoflurane and i.d. injected with the test agents, as 
described above (item 2.3), and four hour later they were killed via an overdose of 
urethane followed by cervical dislocation. The injected skin sites were removed, and the 
myeloperoxidase (MPO) activity was measured as previously described  [30]. The results 
were expressed as units of MPO per mg of protein (or percentage). 
 
2.5.2. Production of H2S by mouse dorsal skin 
The endogenous H2S production in the naïve mouse dorsal skin was carried out 
based on the formation of lead sulfide, according to [31]. Briefly, skin, brain and liver 
were excised and homogenized. After centrifugation (10,000 g, 10 min, 4°C), the 
obtained supernatants (400 µg protein) was incubated with substrates (L-cysteine 10 mM 
and pyridoxal-5’-phosphate 2 mM) for 2h 30min at 37 ºC. The dark dots densities on the 
lead acetate white paper strips (12x8 cm) placed over the 96-wells microplate were 
analyzed from the digitalized images using the software ImageJ (NIH, USA). Hydrogen 
sulfide concentrations were extrapolated from a calibration curve generated with NaHS 
(1.95 - 2000 µM).  
 
2.6. Rat mast cell isolation and quantification of in vitro histamine release by HPLC-
MS/MS 
Rats (n=6) were exsanguinated under deep isoflurane anaesthesia (5% v/v in O2), 
mast cells were isolated from the peritoneal cavity and purified (95%) by Percoll gradients 
(as determined by Cytospin® preparations stained with May-Grünwald Giemsa, and 
trypan blue dye exclusion). Briefly, to 0.5 ml mast cell aliquots (4x105 cells/ml) were 
simultaneously added compound 48/80 (1 µg/ml) and the test agents (Na2S, LR or 
GYY4137 at 100–1000 µM) and incubated at 37C during 15 min. The amount of 
histamine released was quantified by high performance liquid chromatography coupled 
to an electrospray tandem mass spectrometry (HPLC-MS/MS), as described previously 
[32].  
 
2.7. Drugs and reagents  
Lawesson’s reagent (2,4-bis[4-methoxyphenyl]-1,3,2,4-dithiadiphosphatane 2,4- 
disulphide), histamine (2-[1H-imidazol-4-yl]ethanamine), pyridoxal 5′-phosphate, L-
cysteine, glibencamide (5-Chloro-N-[4-(cyclohexylureidosulfonyl) phenethyl]-2-
methoxybenzamide), phenylmethanesulfonyl fluoride (PMSF), -dianisidine 
dihydrochloride (3,3′-dimethoxybenzidine dihydrochloride), aminooxyacetic acid 
(AOAA), urethane (carbamic acid ethyl ester), HTAB (hexadecyl trimethylammonium 
bromide), trypan blue and compound 48/80 (N-methyl-p-methoxyphenethylamine) were 
purchased from Sigma Chemical Co. (St Louis, MO, USA). CMC 
(carboxymethylcellulose) was obtained from Cromoline Química Fina Ltda (Diadema, 
São Paulo, Brazil). Percoll and Na2S.9H2O were purchased from GE Healthcare Bio-
Sciences (Uppsala, Sweden) and Dinâmica Química Contemporânea Ltda (Diadema, São 
Paulo, Brazil), respectively. Isoflurane (1-chloro-2,2,2-trifluoroethyl difluoromethyl 
ether), hydrogen peroxide and lead acetate were purchased from Cristália (Itapira, São 
Paulo, Brazil) and Labsynth® (Diadema, São Paulo, Brazil), respectively. BCA (β-
cyanoalanine) was obtained from Cayman Chemical Company (USA) and GYY4137 was 
synthesized in house, as described in  [33]. 
 
2.8. Statistical analysis 
Data are expressed as mean ± SEM for n animals. Differences among the groups were 
analyzed by one-way ANOVA followed by Bonferroni or Dunnett’s test for multiple 
comparisons, using the software GraphPad Prism (version 4.0, San Diego, CA, USA). 
Values of P lower than 0.05 were taken as signiﬁcant. 
 
3. Results  
 
3.1. Histamine or C48/80-induced pruritus is reduced by H2S donors  
As shown in Figure 1, the i.d. injection of histamine (1 µmol/site) resulted in 
significant increase of pruritus in the dorsal skin compared with the Tyrode injected 
group. The co-injection of histamine with Na2S (1 and 3 nmol/site, P < 0.05; Fig. 1A), 
LR (3 and 10 nmol/site, P < 0.05; Fig. 1B) and GYY4137 (1 nmol/site, P < 0.05; Fig. 1C) 
reduced the number of scratching bouts in a dose-dependent manner compared to 
histamine alone, except that at a higher doses both Na2S and GYY4137 failed to evoke 
this effect. The i.d. injection of higher dose of Na2S (10 nmol/site), LR (10 nmol/site) or 
GYY4137 (10 nmol/site) by itself did not evoke scratching behavior (Fig. 1A-C). 
 Similarly, the i.d. injection of C48/80 (3 µg/site), a mast cells degranulator, also 
evoked a marked number of scratching bouts in comparison with Tyrode (P < 0.05 - P < 
0.001; Fig. 2A-C). This response was significantly inhibited, but not in a dose-dependent 
fashion, by the co-injection with increasing doses of Na2S (1, 3 and 10 nmol/site, P < 
0.05; Fig 2A) or LR (0.3 - 10 nmol/site, P < 0.05 - P < 0.001; Fig 2B). GYY4137 i.d. 
injected in all tested doses (0.3 - 10 nmol/site) failed to significantly inhibit C48/80-
induced pruritus (Fig 2C). None of the H2S donors produced a significant scratching 
behavior compared to Tyrode injected group. 
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Fig. 1. Dose response relationship for H2S-releasing donors on histamine-induced 
scratching bouts. The scratching bouts evoked by i.d. injection of histamine alone or co-
injected with Na2S (0.3 - 10 nmol/site., n = 5 - 10), LR (0.3 - 10 nmol/site., n = 5 - 8) and 
GYY4137 (0.3 - 10 nmol/site., n =5 - 6) are illustrated on panels A, B and C, respectively. 
Independent groups of mice were i.d. injected only with H2S donors at higher doses. 
Dashed line represents the pruritus induced by i.d. injection of vehicle, the Tyrode 
solution. Data are expressed as mean ± SEM. **P < 0.01 –***P < 0.001 vs. Tyrode, #P < 
0.05 vs. histamine (One-way ANOVA followed by the Dunnett’s test). 
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 Fig. 2. Dose-response curves for H2S-releasing donors on C48/80-induced scratching 
bouts. Panels (A), (B) and (C) show the percentage of scratching bouts evoked by C48/80 
alone (3 µg/site; i.d) and co-injected with Na2S (0.3 - 10 nmol/site, n = 5–8), LR (0.3 - 10 
nmol/site, n = 5–7) and GYY4137 (0.3 - 10 nmol/site, n = 7), respectively. A set of mice 
received only i.d. injection of the H2S donors at higher dose. Dashed line represents the 
pruritus evoked by i.d. injection of Tyrode. Data are expressed as mean ± SEM. *P < 0.05 
– ***P < 0.001 vs. Tyrode, #P < 0.05 – ###P < 0.001 vs. C48/80 alone (One-way ANOVA 
followed by the Dunnett’s test). 
 
3.2. Effects of H2S-releasing donors on dorsal skin plasma extravasation and neutrophil 
influx induced by amines (increased MPO activity) 
The i.d. injection of histamine (30 nmol/site) induced a significant (P < 0.001) 
plasma protein extravasation in the mouse dorsal skin in comparison with Tyrode (Fig. 
3). This response was dose-dependently reduced by the co-injection of Na2S (3 - 100 
nmol/site, P < 0.05; Fig. 3A) and LR (1 - 10 nmol/site, P < 0.05; Fig. 3B), but unaffected 
by GYY4137 (Fig. 3C). Neither Tyrode nor H2S donors injected i.d. produced a 
significant increase in plasma extravasation. 
The i.d. injection of C48/80 (3 µg/site) also resulted in significant (P < 0.001) 
amount of plasma extravasation in comparison with Tyrode (Fig. 4). Co-injected with 
H2S donors Na2S and LR, the plasma extravasation induced by C48/80 was significantly 
reduced (P < 0.05) at doses of 30 and 100 nmol/site (Fig. 4A and B). The simultaneous 
injection of GYY4137 with histamine failed to significantly affect the plasma 
extravasation induced by C48/80 (Fig. 4C). None of H2S donors at a higher dose (100 
nmol/site) increased significantly the microvascular permeability when i.d. injected alone 
in the mouse dorsal skin.  
After 4 hours i.d injection of C48/80 in the mouse dorsal skin (3 µg/site), a marked 
(P < 0.001) increase in MPO activity was noticed compared with Tyrode (Fig. 5). The 
i.d. co-injection of Na2S (3, 10 and 30 nmol/site; Fig. 5A), LR (10, 30 and 100 nmol/site; 
Fig. 5B) or GYY4137 (100 nmol/site; Fig. 5C) led to a significant (P < 0.05 - P < 0.001) 
inhibitory effect on C48/80-induced increased MPO activity. At a higher dose, Na2S (100 
nmol/site) failed to inhibit C48/80-induced increased MPO activity compared to this 
compound alone (Fig. 5A). H2S donors had no effects when i.d. injected alone. 
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Fig. 3. Dose-response curves of the H2S donors on plasma extravasation induced by i.d. 
injection of histamine. Panels (A), (B) and (C) show the co-injection effects of Na2S (1 - 
100 nmol/site, n = 5–7), LR (1 - 100 nmol/site, n = 5) and GYY4137 (1 - 100 nmol/site, 
n =7-10) on histamine (30 nmol/site)-induced plasma extravasation. At higher dose, H2S 
donors i.d. injected induced similar plasma extravasation to that produced by its vehicle 
Tyrode (dashed line). Data are expressed as mean ± SEM. ***P < 0.001 vs. Tyrode, #P 
< 0.05 vs. Histamine alone (One-way ANOVA followed by the Dunnett’s test).  
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Fig. 4. Dose-response relationship between H2S-releasing donors on C48/80-induced 
cutaneous plasma extravasation. Panels (A), (B) and (C) illustrate response evoked by i.d. 
injection of C48/80 (3 µg/site) alone and co-injected with Na2S (1 - 100 nmol/site., n = 
6), LR (1 - 100 nmol/site., n = 8) and GYY4137 (1 - 100 nmol/site., n =10), respectively. 
At higher dose, the i.d. of H2S donors induced similar plasma extravasation to that 
produced by its vehicle Tyrode (dashed line). Data are expressed as mean ± SEM. ***P 
< 0.001 vs. Tyrode, #P < 0.05 vs. C48/80 alone (One-way ANOVA followed by the 
Dunnett’s test). 
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Fig. 5. Effects of H2S donors on C48/80-induced increased MPO activity. Panels (A), (b) 
and (C) show the MPO activity evoked by i.d. injection of C48/80 (3 µg/site) alone and 
co-injected with Na2S (1-100 nmol/site., n = 6), LR (1-100 nmol/site., n = 10) and 
GYY4137 (1-100 nmol/site ., n =8), respectively, 4 hours later. At higher doses, H2S 
donors evoked similar response to that evoked by its vehicle Tyrode (dashed line). Data 
are expressed as mean ± SEM. ***P < 0.001 vs. Tyrode, #P < 0.05 - ###P < 0.001 vs. 
C48/80 alone (One-way ANOVA followed by the Dunnett’s test).  
 
3.3. Role of endogenous H2S in C48/80-induced both pruritus and neutrophil influx 
As expected, the i.d. injection of C48/80 (3 µg/site) induced a significant increase 
on the number of scratching bouts (Fig. 6A and B) and MPO activity (Fig. 6C and D). 
The pretreatment of mice with the CSE inhibitor BCA (50 mg/kg; i.p., - 60 min) 
significantly exacerbated (P<0.05) C48/80-induced pruritus and MPO activity compared 
to control group pretreated with saline (Fig.6A and 6C), whilst the pretreatment of 
animals with the nonselective CBS inhibitor AOAA (20 mg/kg; i.p., - 60 min) did not. 
The i.d. injection of Tyrode in mice dorsal skin did not evoke a significant increase in 
MPO activity; however, the pretreatment of mice with BCA or AOAA resulted in a 
significant increase of MPO activity compared to Tyrode response in saline-pretreated 
mice (Fig. 6C and D).  
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Fig. 6. Endogenous blockade of H2S synthesis potentiated C48/80-induced pruritus and 
MPO activity in mouse dorsal skin. Panels (A) and (B) show the effects of pretreatment 
with either the CSE inhibitor, β-cyanoalanine (BCA, 50 mg/kg., -60 min) or the 
nonselective CBS inhibitor aminooxyacetic acid (AOAA, 20 mg/kg., -60 min) in the 
pruritus evoked by C48/80 (n=5-8). Panels (C) and (D) show the same effects of the same 
treatments in C48/80-induced MPO activity (n=5-8). Data are expressed as mean ± 
S.E.M. for n animals. * P <0.05 and *** P <0.001 vs. Tyrode. ##P < 0.01 and ###P < 0.001 
vs. saline pretreated mice. (One-way ANOVA followed by Bonferroni's multiple 
comparison test). 
 
3.4 Determination of H2S in mouse dorsal skin  
 The naïve mouse skin, similarly to the brain, produce a significant and equivalent 
amount of H2S ( 0.3 nmol / mg of protein/min), whereas a marked H2S generation was 
generated in the liver ( 1.2 nmol / mg of protein/min) of naïve mice (Fig. 7). 
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Fig. 7. Constitutive H2S generation in the naïve skin, liver and brain of mice. Panel A shows 
the H2S generation in the skin, liver and brain of naïve animals, expressed as nmol of H2S 
per mg of protein/min, and panel B illustrates the representative corresponding skin, liver 
and brain dark dots densities on the lead acetate white paper strip. Data are expressed as 
mean ± S.E.M. for n = 4 animals.  
 
3.5. Histamine release from mast cells activation is reduced by H2S-releasing donors 
C48/80 (1 µg/ml) markedly stimulated the release of histamine (P < 0.001) from 
rat peritoneal mast cells compared with histamine spontaneously released from mast cells 
treated only with buffer (KRP; Fig. 8). The concomitant incubation of mast cells with 
C48/80 and Na2S (100 and 1000 µM; P < 0.05 - P < 0.01) or LR (500 - 1000 µM; P < 
0.05 - P < 0.001) resulted in significant decrease of histamine release from these cells. In 
all tested concentrations, GYY4137 did not prevent histamine release from C48/80-
induced mast cell degranulation (Fig. 8). The % of histamine released from mast cells 
incubated with H2S donors alone matched with KRP value (Fig. 8).  
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Fig. 8. Spontaneous, but not slow, H2S donors reduce C48/80-induced mast cell 
degranulation. Black bar illustrates the % of histamine released from mast cells treated 
with C48/80 (1 µg/ml) in krebs ringer phosphate solution (KRP). Cross-hatched bars 
show the % of histamine release from mast cells in response to C48/80 plus Na2S, LR or 
GYY4137 (100 - 1000 µM). Data are expressed as % of histamine release. Values are 
presented as mean ± SEM of three independent experiments. ***P < 0.001 vs. KRP (basal 
release), #P < 0.05- ## P < 0.01-### P < 0.001 vs. C48/80 alone (One-way ANOVA 
followed by Bonferroni's multiple comparison test). 
 3.6. Lack of involvement of KATP channels in the antipruritic effect of H2S 
The pretreatment of mice with glibenclamide (10 or 30 mg/kg; i.p., - 30 min) 
significantly inhibited, at both doses, the KATP channel opener pinacidil (10 and 30 
nmol/site)-induced exacerbation of plasma extravasation evoked by histamine (Fig. 9A), 
thus suggesting an effective blockade of this channel. The pretreatment of animals with 
10 mg/kg of glibenclamide did not significantly affect histamine-induced plasma 
extravasation (Fig. 9B) or pruritus (Fig. 9C) compared to histamine responses in animals 
pretreated with vehicle CMC. Likewise, glibenclamide treatment did not alter the 
protective effect of Na2S (3 or 30 nmol/site) against histamine-induced plasma 
extravasation or pruritus (Fig. 9B-C).  
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Fig. 9. Blockade of KATP channels failed to reverse Na2S-induced protective effect against 
histamine-induced plasma extravasation and pruritus. Panel (A) shows the effect of 
glibenclamide (10 or 30 mg/kg., i.p., - 30 min) or its vehicle (CMC) on pinacidil (10 or 
30 nmol/site)-induced potentiating of plasma extravasation in response to i.d. of 
histamine (30 nmol/site; n=5), whereas panels (B) and (C) show the effects of histamine 
in glibenclamide pretreated group (10 mg/kg., i.p., - 30 min) in addition to Na2S (30 
nmol/site., n = 5 - 6) and pruritus (1 µmol/site., n = 5 - 10). Data are presented as mean ± 
S.E.M. for n animals. ** P <0.01 - *** P <0.001 vs. Tyrode + CMC, ## P <0.01-### P 
<0.001 vs. histamine + CMC, +P <0.05 - +++P <0.001 vs histamine + pinacidil. (One-way 
ANOVA followed by Bonferroni's test). 
 
Discussion 
 
The major finding in this study is to show that the spontaenous H2S donors Na2S 
and LR significantly ameliorated pruritus and the acute cutaneous inflammation induced 
by histamine and C48/80 in the mouse dorsal skin, being this effect less pronounced (or 
absent) in mice treated with the slow H2S-releasing donor GYY4137, whilst the 
endogenous blockade of H2S biosynthesis aggravates skin inflammation and pruritus.  
Histamine-induced plasma extravasation (oedema) is mainly processed by 
activation of H1-histaminergic receptors and, to a lesser extent, H2 receptors expressed 
in the skin vessels of both rodents [34,35] and humans [36,37]. Herein, the simultaneous 
i.d. injection of H2S donors Na2S or LR within the 0.3-10 nmoles/site dose range, 
significantly inhibited pruritus and plasma extravasation produced by histamine, even 
though it did not follow a clear dose-dependent response. Instead, a trend to biphasic 
pattern in the scratching behavior (pruritus) and plasma protein extravasation was 
observed with these H2S donors, in particular with Na2S.  
Even though we have used smaller doses of Na2S compared to previous study 
[27], it is possible that as this compound instantaneously delivers H2S, the higher tested 
dose (100 nmol/site) led to an immediate non-physiologically concentration of H2S in the 
local microcirculation, which may be distinct from that seen in the dorsal skin. In line 
with this, we provide the first evidence that the mouse dorsal healthy skin constitutively 
produces low amounts of H2S ( 0.3 nmol of H2S per mg of protein per min), similarly 
to that produced by the brain but less than that produced by the liver. Thus, these results 
point to the same suggestion made by previous studies, in terms that the application of 
high doses of a fast H2S-releasing donors can rapidly lead to elevated concentrations of 
this mediator, which in turn may result in toxic effects, rather than the beneficial ones 
seen with low amounts of H2S [33,38–41]. 
Histamine exerts its inflammatory effects, in part, through NO generation in situ  
[35], since the blockade of NOS significantly inhibited histamine-induced plasma 
extravasation in human nasal airway [42]. Interestingly, Ali and co-workers [43] 
demonstrated that low concentration of H2S or spontaneous H2S donors reversed 
histamine, but not isoprenaline-induced vasodilatation, possibly via a direct chemical 
reaction between H2S and NO, which may lead to the formation of a nitrosothiol [44] or 
even nitroxyl species (NO-/HNO)  [45] of poor vasorelaxant activities.  
Similarly to histamine, the cationic secretagogue C48/80 also induces a marked 
pruritus behavior and skin inflammation characterized by plasma extravasation and 
neutrophil influx, except for the more pronounced response observed with the latter when 
applied at similar doses mainly due to the exocytosis of multiple preformed mediators 
from mast cells (e.g. histamine, 5-HT, etc.) on both blood vessels and neurons, via 
interactions with their respective receptors. In fact, C48/80 effects can be significantly 
inhibited by antagonists of histamine H1 receptors, 5-HT or substance P (NK1) receptors 
[36,46,47].  
C48/80-induced plasma extravasation and pruritus was partially, but significantly, 
inhibited by the simultaneous co-injection of the spontaenous H2S donors Na2S or LR, 
whereas neither histamine nor C48/80-induced plasma leakage was significantly affected 
by the slow H2S-releasing donor GYY4137. It is thus possible that a significant amount 
of H2S immediately available in the microvascular bed during the initial phases of the 
vascular response is necessary to interact with NO generated by histamine (or the 
histamine releaser C48/80), and consequently inhibit its potentiating action on 
microvascular permeability. Indeed, it is well established that plasma extravasation 
occurs immediately after the i.d. injection of chemical mediators (such as histamine), 
whereas the leukocyte recruitment into the cutaneous tissue takes longer periods of time 
(>3 h). In agreement, our results show that 4 hours after the i.d. injection of C48/80 a 
marked neutrophil influx ocurs (measured as MPO activity), and this response was 
effectively reduced by all the H2S releasing donors. It is thus possible that the GYY4137 
compound may have released enough H2S along this time, which in turn can counteract 
with the dynamic of leukocyte influx in the microcirculation in response to C48/80. 
A direct stabilizing effect of H2S on mast cells degranulation could explain  the 
reduced leukocyte influx in response to C48/80. In order to test this hypothesis we 
performed in vitro experiments using rat peritoneal mast cells stimulated with C48/80 and 
measured the release of histamine. In fact, we observed that Na2S and LR, but not 
GYY4137 prevented mast cell degranulation. In agreement with our data, Zanardo and 
co-workers [48] have shown that spontaneous H2S donors, such as Na2S, NaHS and LR, 
markedly inhibited carrageenan-induced leukocyte adhesion and infiltration in a rodent 
air pouch model. Similar results were obtained by Ekundi-Valentim and co-workers 
[16,20] in the model of carrageenan-induced synovitis in rats, and by Fiorucci and co-
workers [49] in the acetyl salycilic acid-induced gastric injury in rats. Reduced expression 
of the adhesion molecules ICAM-1, VCAM-1, LFA-1, P-selectin, E-selectin in both 
endothelium and leukocytes has been suggested as the underlying mechanism of H2S-
mediated inhibition of leukocyte influx [40,48–50].  
The activation of KATP channels by H2S has been shown as the mechanism 
underlying the inhibitory effects of this mediator in a variety of experimental approaches, 
including aspirin-induced leukocyte adherence in mesenteric venules [48] and high 
glucose-induced cardiac cells injury  [51]. However, this not seem to be the cause beyond 
the protective effects of the spontaneous H2S donors against histamine-induced pruritus 
and skin inflammation, as pretreatment of mice with glibenclamide, a selective KATP 
channels blocker, did not antagonize the protective effects of H2S, even when used at 
doses that abolish the vasodilatation induced in the mouse dorsal skin by the KATP channel 
opener pinacidil. 
Compound 48/80 has been largely used as an IgE independent activator of mast 
cells, which mainly due to histamine release (and activation of peripheral H1 and H4 
receptors), results in sensitization of afferent nerves [52,53]. Similarly to the spontaneous 
H2S donor Na2S, GYY4137 inhibited histamine-induced pruritus; however, this was not 
the case with C48/80-induced pruritus. Thus, either the intensity of response evoked by 
histamine released from C48/80 was higher than exogenous histamine when paralleled 
by the low availability of H2S released from GYY4137 in situ on the peripheral afferent 
neurons or it is possibly that C48/80 produces scratching behavior that somehow depends 
on functional changes evoked by direct activation of pruriceptors. While direct excitatory 
effects of C48/80 on dorsal root ganglion (DRG), enteric neurons and visceral afferents 
can occur independently of mast cell activation [54], other works show that the 
mechanism involved in C48/80-induced nociception is mediated by a cascade activation 
that starts after mast cell activation, including the release of mediators that can activate 
these nociceptors and promote pain [55].  
Curiously, and in contrast to our findings, a recent work by Wang and co-workers 
[27] has shown that the i.d. injection of mice with the spontaneous H2S donors NaHS and 
Na2S, at mM range (7 – 280 and 1.7 – 67, respectively), led to a marked itching behavior 
and touch-evoked itching (allokinesis), while inhibition of endogenous H2S synthesis by 
pretreatment of the mice with CSE and CBS inhibitors reduced C48/80-induced pruritus. 
Previously, Elies and co-workers [56] showed that NaHS at low concentrations (100-300 
µM) markedly inhibits Ca2+v3.2 T-type calcium channel in HEK293 cells, while NaHS at 
high concentrations (3-10 mM) led to a marked activation of these channels, possibly due 
to the resultant high Na+ concentrations. In line with these findings, we speculated that 
the presence of these high Na+ concentrations may explain the discrepancies between our 
results and those shown in Wang's paper. We also show that inhibition of endogenous 
H2S biosynthesis by BCA, but not by AOAA, resulted in enhanced C48/80-induced 
scratching behavior in addition to increased MPO activity. Again, the C48/80-induced 
pruritus results are in contrast with those produced by Wang and co-workers [27], but the 
increament in MPO activity are agreement with previous work by Zanardo and co-
workers [48], in which they showed that animals treated with BCA exhibited enhanced 
leukocyte adherence and infiltration in an air pouch model [47]. Thus, it is possible that 
the administration route used by these authors (i.d.) may account for the discrepancies 
considering that local desensitization effects may be produced by these drugs 
independently of H2S generation. 
In addition to potentiating the scratching behavior, H2S synthesis blockade by 
BCA or AOAA has also enhanced neutrophil influx into the dorsal skin, under basal 
conditions. Furthermore, the non-selective inhibition of CBS/CSE by AOAA increased 
the basal neutrophil influx to an extent similar to that induced by C48/80, thus reflecting 
the protective role of endogenous H2S in the normal skin physiology. 
 
Conclusions 
Altogether the results shown in this study provide the first evidence that 
endogenous H2S, as well as the administration of low doses of spontaneous H2S donors, 
such as LR and Na2S, exert protective roles against histamine/mast cell-mediated acute 
pruritus and inflammation of the dorsal mouse skin, independently of H2S action on KATP 
channels. 
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